SHANGHAI CANCER INSTITUTE;CARSGEN THERAPEUTICS CO., LTD.
发明人:
Zonghai LI,Peng WANG,Hua JIANG
申请号：
US16618047
公开号：
US20200138864A1
申请日:
2018.05.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are methods of treating a subject exhibiting a cell that expresses Wilms tumor protein 1 (WT1). The methods typically utilize anti-WT1 antigen binding units or chimeric antigen receptor immunoresponsive cells to a subject in need thereof to effect killing of tumor cells.
